The Global Plasma Therapy market is fuelling the market growth in the wake of a cost-effective and rapid healing process
The global Plasma therapy market has the potential to grow with USD 327.52 million with bolstering CAGR in the forecast period from 2020-2027. The emerging demand for plasma therapy is owing to the outbreak of coronavirus, emerging cases from sports injuries, and people with low immunity are bolstering market share for the global plasma therapy market.
The plasma therapy is helping to save the lives of people fighting with coronavirus. It is mainly through the way of blood transfusion that the antibodies in the blood of the rehabilitated patients are given to critically ill patients to help the patients' immune system fight the new coronavirus.
The effectiveness is reflected in the reduction of viral load to entirely negative, the increase in the proportion of lymphocytes, the rise in blood oxygen saturation, and the improvement of vital signs and symptoms such as body temperature and breathing.
Moreover, through technological innovation, production process upgrades, product quality improvement, and the expansion of new indications, the demand for plasma therapy is bolstering. Also, the combined treatment of ultrasound and platelet-rich plasma has become an original method for the treatment of various diseases in orthopedics.
Type overview in the Global Plasma Therapy Market
Based on the type, the global plasma therapy market categorized into Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin. The leukocyte-rich fibrin type segment accounted for the largest share in the global plasma therapy market. The protein present in leukocyte-rich fibrin help in healing the patient faster. Also, the healing process creates the potential protein cell network that reduces the pain in bones and other tissue post-treatment.
Source overview in the Global Plasma Therapy Market
Based on the source, the global plasma therapy market segmented into Autologous, Allogenic. The autologous source segment is estimated to account for the largest share of the plasma therapy market in the forecast period. It is mainly owing to the rising cases of sports injuries that have occurred that affect the bone and other tissues. With the adoption of plasma therapy, it heals the bones faster, and new treatments are propelling the market share.
Application overview in the Global Plasma Therapy Market
Based on the application, the global plasma therapy market classified into Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Others. The dermatology segment is dominating the market share of the global plasma therapy market. The rising demand for facial rejuvenation process increases the cases of cosmetic procedures. Therefore, the dermatology segment is anticipating bolstering the market share for plasma therapy in the global market.
End-Use overview in the Global Plasma Therapy Market
Based on the end-user, the global plasma therapy market bifurcated into Hospitals & Clinics, Research Institutions. The hospitals & clinics segment has dominated the largest share in the global plasma therapy market. It is owing to the rapid growth of population and urbanization, and the emerging need for increasing health facilities and with cost-effective, quick healing therapies.
Region overview in the Global Plasma Therapy Market
Based on geography, the global plasma therapy market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region is dominating the market share of the global plasma therapy market. It is mainly due to the rising population of the geriatric population, increasing cases of autologous, and emerging number trauma cases are fueling the market demand for the global plasma therapy.
Global Plasma Therapy Market: Competitive Landscape
Companies such as BioLife Plasma Services, Cambryn Biologics LLC, Biotest, CSL Ltd., Grifols International S.A., Kedrion S.p.A. LFB, Bio Products Laboratory Ltd., China Biologic Products, Inc., Octapharma and others are key players in the global plasma therapy market.
Global Plasma Therapy Market Report Content 1. Research Strategic Development 1.1. Market Modelling 1.2. Product Analysis 1.3. Market Trend and Economic Factors Analysis 1.4. Market Segmental Analysis 1.5. Geographical Mapping 1.6. Country Wise Segregation 2. Research Methodology 2.1. Identification of Target Market 2.2. Data Acquisition 2.3. Refining of Data/ Data Transformations 2.4. Data Validation through Primary Techniques 2.5. Exploratory Data Analysis 2.6. Graphical Techniques/Analysis 2.7. Quantitative Techniques/Analysis 2.8. Visual Result/Presentation 3. Executive Summary 4. Market Insights 4.1. Economic Factor Analysis 4.1.1. Drivers 4.1.2. Trends 4.1.3. Opportunities 4.1.4. Challenges 4.2. Competitors & Product Analysis 4.3. Regulatory Framework 4.4. Company market share analysis, 2019 4.5. Porter's Five forces analysis 4.6. New Investment Analysis 4.7. PESTEL Analysis 5. Global Plasma Therapy Market Overview 5.1. Market Size & Forecast, 2016-2027 5.1.1. Demand 5.1.1.1. By Value (USD Million) 5.2. Market Share & Forecast, 2016-2027 5.2.1. By Type 5.2.1.1. Pure PRP 5.2.1.2. Leucocyte-rich PRP 5.2.1.3. Pure Platelet-rich Fibrin (PRF) 5.2.1.4. Leukocyte-rich Fibrin (L-PRF) 5.2.2. By Source 5.2.2.1. Autologous 5.2.2.2. Allogenic 5.2.3. By Application 5.2.3.1. Orthopaedics 5.2.3.1.1. Arthritis 5.2.3.1.2. Chronic Tendinitis 5.2.3.1.3. Bone Repair & Regeneration 5.2.3.2. Dermatology 5.2.3.2.1. Androgenic Alopecia 5.2.3.2.2. Plastic Surgery 5.2.3.3. Dental 5.2.3.4. Cardiac Muscle Injury 5.2.3.5. Nerve Injury 5.2.3.6. Others 5.2.4. By End-Use 5.2.4.1. Hospitals & Clinics 5.2.4.2. Research Institutions 5.2.5. By Region 5.2.5.1. Europe 5.2.5.2. North America 5.2.5.3. Asia Pacific 5.2.5.4. South America 5.2.5.5. Middle East & Africa 6. Europe Plasma Therapy Market Overview 6.1. Europe Plasma Therapy Market Size & Forecast, 2016-2027 6.1.1. Demand 6.1.1.1. By Value (USD Million) 6.2. Europe Plasma Therapy Market Share & Forecast, 2016-2027 6.2.1. By Type 6.2.1.1. Pure PRP 6.2.1.2. Leucocyte-rich PRP 6.2.1.3. Pure Platelet-rich Fibrin (PRF) 6.2.1.4. Leukocyte-rich Fibrin (L-PRF) 6.2.2. By Source 6.2.2.1. Autologous 6.2.2.2. Allogenic 6.2.3. By Application 6.2.3.1. Orthopaedics 6.2.3.1.1. Arthritis 6.2.3.1.2. Chronic Tendinitis 6.2.3.1.3. Bone Repair & Regeneration 6.2.3.2. Dermatology 6.2.3.2.1. Androgenic Alopecia 6.2.3.2.2. Plastic Surgery 6.2.3.3. Dental 6.2.3.4. Cardiac Muscle Injury 6.2.3.5. Nerve Injury 6.2.3.6. Others 6.2.4. By End-Use 6.2.4.1. Hospitals & Clinics 6.2.4.2. Research Institutions 6.2.5. By Country 6.2.5.1. Germany 6.2.5.2. UK 6.2.5.3. France 6.2.5.4. Italy 6.2.5.5. Rest of Europe 6.2.6. Company Market Share (Top 3-5) 6.2.7. Economic Impact Study on Europe Plasma Therapy Market 7. North Plasma Therapy Market Overview 7.1. North America Plasma Therapy Market Size & Forecast, 2016-2027 7.1.1. Demand 7.1.1.1. By Value (USD Million) 7.2. North America Plasma Therapy Market Share & Forecast, 2016-2027 7.2.1. By Type 7.2.1.1. Pure PRP 7.2.1.2. Leucocyte-rich PRP 7.2.1.3. Pure Platelet-rich Fibrin (PRF) 7.2.1.4. Leukocyte-rich Fibrin (L-PRF) 7.2.2. By Source 7.2.2.1. Autologous 7.2.2.2. Allogenic 7.2.3. By Application 7.2.3.1. Orthopaedics 7.2.3.1.1. Arthritis 7.2.3.1.2. Chronic Tendinitis 7.2.3.1.3. Bone Repair & Regeneration 7.2.3.2. Dermatology 7.2.3.2.1. Androgenic Alopecia 7.2.3.2.2. Plastic Surgery 7.2.3.3. Dental 7.2.3.4. Cardiac Muscle Injury 7.2.3.5. Nerve Injury 7.2.3.6. Others 7.2.4. By End-Use 7.2.4.1. Hospitals & Clinics 7.2.4.2. Research Institutions 7.2.5. By Country 7.2.5.1. US 7.2.5.2. Canada 7.2.5.3. Mexico 7.2.6. Company Market Share (Top 3-5) 7.2.7. Economic Impact Study on North America Plasma Therapy Market 8. Asia Pacific Plasma Therapy Market Overview 8.1. Asia Pacific Plasma Therapy Market Size & Forecast, 2016-2027 8.1.1. Demand 8.1.1.1. By Value (USD Million) 8.2. Asia Pacific Plasma Therapy Market Share & Forecast, 2016-2027 8.2.1. By Type 8.2.1.1. Pure PRP 8.2.1.2. Leucocyte-rich PRP 8.2.1.3. Pure Platelet-rich Fibrin (PRF) 8.2.1.4. Leukocyte-rich Fibrin (L-PRF) 8.2.2. By Source 8.2.2.1. Autologous 8.2.2.2. Allogenic 8.2.3. By Application 8.2.3.1. Orthopaedics 8.2.3.1.1. Arthritis 8.2.3.1.2. Chronic Tendinitis 8.2.3.1.3. Bone Repair & Regeneration 8.2.3.2. Dermatology 8.2.3.2.1. Androgenic Alopecia 8.2.3.2.2. Plastic Surgery 8.2.3.3. Dental 8.2.3.4. Cardiac Muscle Injury 8.2.3.5. Nerve Injury 8.2.3.6. Others 8.2.4. By End-Use 8.2.4.1. Hospitals & Clinics 8.2.4.2. Research Institutions 8.2.5. By Country 8.2.5.1. China 8.2.5.2. India 8.2.5.3. Japan 8.2.5.4. Australia 8.2.5.5. Rest of Asia Pacific 8.2.6. Company Market Share (Top 3-5) 8.2.7. Economic Impact Study on Asia Pacific Plasma Therapy Market 9. South America Plasma Therapy Market Overview 9.1. South America Plasma Therapy Market Size & Forecast, 2016-2027 9.1.1. Demand 9.1.1.1. By Value (USD Million) 9.2. South America Plasma Therapy Market Share & Forecast, 2016-2027 9.2.1. By Type 9.2.1.1. Pure PRP 9.2.1.2. Leucocyte-rich PRP 9.2.1.3. Pure Platelet-rich Fibrin (PRF) 9.2.1.4. Leukocyte-rich Fibrin (L-PRF) 9.2.2. By Source 9.2.2.1. Autologous 9.2.2.2. Allogenic 9.2.3. By Application 9.2.3.1. Orthopaedics 9.2.3.1.1. Arthritis 9.2.3.1.2. Chronic Tendinitis 9.2.3.1.3. Bone Repair & Regeneration 9.2.3.2. Dermatology 9.2.3.2.1. Androgenic Alopecia 9.2.3.2.2. Plastic Surgery 9.2.3.3. Dental 9.2.3.4. Cardiac Muscle Injury 9.2.3.5. Nerve Injury 9.2.3.6. Others 9.2.4. By End-Use 9.2.4.1. Hospitals & Clinics 9.2.4.2. Research Institutions 9.2.5. By Country 9.2.5.1. Brazil 9.2.5.2. Argentina 9.2.5.3. Rest of South America 9.2.6. Company Market Share (Top 3-5) 9.2.7. Economic Impact Study on South America Plasma Therapy Market 10. Middle East & Africa Plasma Therapy Market Overview 10.1. Middle East & Africa Plasma Therapy Market Size & Forecast, 2016-2027 10.1.1. Demand 10.1.1.1. By Value (USD Million) 10.2. Middle East & Africa Plasma Therapy Market Share & Forecast, 2016-2027 10.2.1. By Type 10.2.1.1. Pure PRP 10.2.1.2. Leucocyte-rich PRP 10.2.1.3. Pure Platelet-rich Fibrin (PRF) 10.2.1.4. Leukocyte-rich Fibrin (L-PRF) 10.2.2. By Source 10.2.2.1. Autologous 10.2.2.2. Allogenic 10.2.3. By Application 10.2.3.1. Orthopaedics 10.2.3.1.1. Arthritis 10.2.3.1.2. Chronic Tendinitis 10.2.3.1.3. Bone Repair & Regeneration 10.2.3.2. Dermatology 10.2.3.2.1. Androgenic Alopecia 10.2.3.2.2. Plastic Surgery 10.2.3.3. Dental 10.2.3.4. Cardiac Muscle Injury 10.2.3.5. Nerve Injury 10.2.3.6. Others 10.2.4. By End-Use 10.2.4.1. Hospitals & Clinics 10.2.4.2. Research Institutions 10.2.5. By Country 10.2.5.1. Saudi Arabia 10.2.5.2. UAE 10.2.5.3. South Africa 10.2.5.4. Rest of Middle East & Africa 10.2.6. Company Market Share (Top 3-5) 10.2.7. Economic Impact Study on Middle East & Africa Plasma Therapy Market 11. Competitor Analysis 11.1. Company Description 11.2. Financial Analysis 11.3. Key Products 11.4. Key Management Personnel 11.5. Contact Address 11.6. SWOT Analysis 11.7. Company Profile 11.7.1.1. BioLife Plasma Services 11.7.1.2. Cambryn Biologics LLC 11.7.1.3. Biotest 11.7.1.4. CSL Ltd. 11.7.1.5. Grifols International S.A. 11.7.1.6. Kedrion S.p.A. LFB 11.7.1.7. Bio Products Laboratory Ltd. 11.7.1.8. China Biologic Products, Inc. 11.7.1.9. Octapharma 11.7.1.10. Other players
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Medical Devices | Pages : 233 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Medical Devices | Pages : 122 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 125 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 130 |
| Price : US$ 3500 | Date : Mar 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 124 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
